64 related articles for article (PubMed ID: 1795779)
1. [Thrombolysis and myocardial infarction].
Bertini G
Minerva Anestesiol; 1991 Dec; 57(12):1499-502. PubMed ID: 1795779
[No Abstract] [Full Text] [Related]
2. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
Kobusiak-Prokopowicz M; Mysiak A
Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
[TBL] [Abstract][Full Text] [Related]
3. The management of acute myocardial infarction. Does thrombolysis have a place?
Warren RJ
Aust Fam Physician; 2000 May; 29(5):436-9. PubMed ID: 10835781
[TBL] [Abstract][Full Text] [Related]
4. Thrombolytic therapy in acute myocardial infarction.
Woo KS; White HD
Curr Opin Cardiol; 1994 Jul; 9(4):471-82. PubMed ID: 7919592
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications of thrombolytic therapy.
Mair FS
Am Fam Physician; 1996 Nov; 54(6):2041-8. PubMed ID: 8900363
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of captopril before thrombolysis in acute myocardial infarction: preliminary findings.
Di Pasquale P; Barone G; Paterna S; Cannizzaro S; Giubilato A
Drugs Exp Clin Res; 1990; 16(11):581-9. PubMed ID: 2101781
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress after acute myocardial infarction: effect of thrombolytic treatment.
Kharb S; Singh V; Ghalaut PS; Singh GP
J Assoc Physicians India; 2000 Jun; 48(6):578-80. PubMed ID: 11273533
[TBL] [Abstract][Full Text] [Related]
8. Nonhemorrhagic complications of coronary thrombolysis.
Johnstone D; Roy L
Can J Cardiol; 1993; 9(6):511-5. PubMed ID: 8221345
[No Abstract] [Full Text] [Related]
9. [The possible limits of thrombolysis: reocclusion and reperfusion damage].
Ambrosio G; Golino P; Chiariello M
Cardiologia; 1991 Dec; 36(12 Suppl 1):421-33. PubMed ID: 1841798
[TBL] [Abstract][Full Text] [Related]
10. Thrombolysis and its sequelae. Calcium antagonists as potential adjunctive therapy.
Roberts R
Circulation; 1989 Dec; 80(6 Suppl):IV93-101. PubMed ID: 2513147
[TBL] [Abstract][Full Text] [Related]
11. Thrombolysis in myocardial infarction--for whom?
Bhagwat AR
J Assoc Physicians India; 1991 Apr; 39(4):333-5. PubMed ID: 1844809
[No Abstract] [Full Text] [Related]
12. Clinical management of patients receiving thrombolytic therapy.
Daily EK
Heart Lung; 1991 Sep; 20(5 Pt 2):552-65. PubMed ID: 1894539
[TBL] [Abstract][Full Text] [Related]
13. Myocardial revascularization in acute myocardial infarction.
Sharma S; Wasir HS
J Assoc Physicians India; 1993 Feb; 41(2):103-9. PubMed ID: 8335599
[No Abstract] [Full Text] [Related]
14. Conundrums in coronary thrombolysis: the TIMI-II/TIMI-III flow dichotomy and the denominator problem.
Sobel BE
Coron Artery Dis; 1996 Jan; 7(1):81-2. PubMed ID: 8773438
[No Abstract] [Full Text] [Related]
15. [Thrombolysis for evolving myocardial infarction in a rural primary care clinic].
Katz A; Caspi M; Zure N; Presma J; Shamai Z; Ovsyshcher I
Harefuah; 1993 Jul; 125(1-2):11-3, 64, 63. PubMed ID: 8225057
[TBL] [Abstract][Full Text] [Related]
16. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
[No Abstract] [Full Text] [Related]
17. [The protective effect of trimetazidine on the myocardium against reperfusion injury during thrombolytic therapy of acute infarction].
Rebrova TIu; Afanas'eva SA; Perchatkin VA; Maksimov IV; Markov VA
Eksp Klin Farmakol; 2004; 67(2):27-30. PubMed ID: 15188756
[TBL] [Abstract][Full Text] [Related]
18. [Study of no-reflow phenomenon after reperfusion for acute myocardial infarction].
Yang YJ; Zhao JL
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2169-70. PubMed ID: 16321176
[No Abstract] [Full Text] [Related]
19. [Early evaluation of results from systemic thrombolysis in acute myocardial infarct: the value of troponin I].
Giraldi F; Grazi S; Guazzi MD
Cardiologia; 1998 May; 43(5):485-91. PubMed ID: 9701879
[TBL] [Abstract][Full Text] [Related]
20. [Physiopathologic basis of the use of thrombolytic agents during the acute phase of myocardial infarction].
Castaigne A; Duval-Moulin AM; Dubois-Randé JL; Merlet P
Arch Mal Coeur Vaiss; 1989 Oct; 82 Spec No 3():15-20. PubMed ID: 2512883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
